1992, ISBN 185158434X, 160 p., [1] leaf of plates
Book
Journal of Hazardous Materials, ISSN 0304-3894, 10/2019, Volume 378, p. 120766
Exposure to polybrominated diphenyl ethers (PBDEs), is closely associated with the occurrence of obesity and non-alcoholic fatty liver disease (NAFLD), yet...
Obesity | Oxidative stress | Lipidomics | Fatty liver | Liver fibrosis | BDE 47 | LIPID-METABOLISM | POLYBROMINATED DIPHENYL ETHERS | PATHOGENESIS | ENVIRONMENTAL SCIENCES | ENGINEERING, ENVIRONMENTAL | ARYL-HYDROCARBON RECEPTOR | FLAME-RETARDANT | INFLAMMATION | DISEASE | EXPRESSION
Obesity | Oxidative stress | Lipidomics | Fatty liver | Liver fibrosis | BDE 47 | LIPID-METABOLISM | POLYBROMINATED DIPHENYL ETHERS | PATHOGENESIS | ENVIRONMENTAL SCIENCES | ENGINEERING, ENVIRONMENTAL | ARYL-HYDROCARBON RECEPTOR | FLAME-RETARDANT | INFLAMMATION | DISEASE | EXPRESSION
Journal Article
Applied Physics Letters, ISSN 0003-6951, 12/2013, Volume 103, Issue 23
Journal Article
9.
Full Text
In0.53Ga0.47As Channel MOSFETs with self-aligned InAs source/drain formed by MEE regrowth
IEEE Electron Device Letters, ISSN 0741-3106, 2009, Volume 30, Issue 11, pp. 1128 - 1130
We report Al2O3/In0.53Ga0.47 As MOSFETs having both self-aligned in situ Mo source/drain ohmic contacts and self-aligned InAs source/drain n(+) regions formed...
Migration-enhanced epitaxial regrowth | III-V MOSFET | Source/drain regrowth | InGaAs MOSFET | InAs source/drain | MOBILITY | TRANSCONDUCTANCE | migration-enhanced epitaxial regrowth | GATE-LENGTH | source/drain regrowth | INGAAS | ENGINEERING, ELECTRICAL & ELECTRONIC
Migration-enhanced epitaxial regrowth | III-V MOSFET | Source/drain regrowth | InGaAs MOSFET | InAs source/drain | MOBILITY | TRANSCONDUCTANCE | migration-enhanced epitaxial regrowth | GATE-LENGTH | source/drain regrowth | INGAAS | ENGINEERING, ELECTRICAL & ELECTRONIC
Journal Article
Optics Letters, ISSN 0146-9592, 01/2017, Volume 42, Issue 2, pp. 338 - 341
We demonstrate the first electrically pumped continuous-wave (CW) III-V semiconductor lasers epitaxially grown on on-axis (001) silicon substrates without...
Thresholds | Quantum dots | Lasers | Silicon substrates | Lasing | Epitaxial growth | Devices | Group III-V semiconductors
Thresholds | Quantum dots | Lasers | Silicon substrates | Lasing | Epitaxial growth | Devices | Group III-V semiconductors
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 3, pp. S15 - S16
Journal Article
Texas Heart Institute Journal, ISSN 0730-2347, 06/2019, Volume 46, Issue 3, pp. 203 - 206
The platelet aggregation inhibitor ticagrelor, a P2Y12 receptor antagonist, is widely used after angioplasty in patients with acute coronary syndrome. Clinical...
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 03/2016, Volume 87, Issue 4, pp. 671 - 677
Objectives The aim of this analysis is to evaluate potential differences according to gender in terms of acute and 30‐day clinical outcomes in patients...
coronary artery disease | clinical study | percutaneous coronary intervention | female | vascular calcification | CARDIAC & CARDIOVASCULAR SYSTEMS | FOLLOW-UP | WOMEN | SPEED ROTATIONAL ATHERECTOMY | HEART-ASSOCIATION | SEX DIFFERENCE | INTERVENTION | ELUTING STENT IMPLANTATION | CLINICAL-OUTCOMES | ARTERY-DISEASE | REGISTRY | Atherectomy, Coronary - methods | Age Factors | Health Status Disparities | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Vascular Calcification - diagnostic imaging | Male | Percutaneous Coronary Intervention - instrumentation | Time Factors | Aged, 80 and over | Vascular Calcification - mortality | Female | Retrospective Studies | Stents | Atherectomy, Coronary - mortality | Severity of Illness Index | Hospital Mortality | Risk Factors | Atherectomy, Coronary - adverse effects | Treatment Outcome | Clinical Trials as Topic | Coronary Artery Disease - mortality | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Sex Factors | Aged | Vascular Calcification - therapy | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Heart | Care and treatment | Coronary artery bypass | Analysis | Endarterectomy | Coronary heart disease
coronary artery disease | clinical study | percutaneous coronary intervention | female | vascular calcification | CARDIAC & CARDIOVASCULAR SYSTEMS | FOLLOW-UP | WOMEN | SPEED ROTATIONAL ATHERECTOMY | HEART-ASSOCIATION | SEX DIFFERENCE | INTERVENTION | ELUTING STENT IMPLANTATION | CLINICAL-OUTCOMES | ARTERY-DISEASE | REGISTRY | Atherectomy, Coronary - methods | Age Factors | Health Status Disparities | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Vascular Calcification - diagnostic imaging | Male | Percutaneous Coronary Intervention - instrumentation | Time Factors | Aged, 80 and over | Vascular Calcification - mortality | Female | Retrospective Studies | Stents | Atherectomy, Coronary - mortality | Severity of Illness Index | Hospital Mortality | Risk Factors | Atherectomy, Coronary - adverse effects | Treatment Outcome | Clinical Trials as Topic | Coronary Artery Disease - mortality | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Sex Factors | Aged | Vascular Calcification - therapy | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Heart | Care and treatment | Coronary artery bypass | Analysis | Endarterectomy | Coronary heart disease
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 169 - 176
Summary Background Patients with chronic lymphocytic leukaemia (CLL) with TP53 aberrations respond poorly to first-line chemoimmunotherapy, resulting in early...
Hematology, Oncology and Palliative Medicine | ALEMTUZUMAB | 17P DELETION | CLL | ONCOLOGY | CYCLOPHOSPHAMIDE | RITUXIMAB | INITIAL THERAPY | BTK | OPEN-LABEL | PROLIFERATION | ELDERLY-PATIENTS | Single-Blind Method | Pyrazoles - therapeutic use | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Neoplasm Recurrence, Local - mortality | Tumor Suppressor Protein p53 - genetics | Neoplasm Recurrence, Local - pathology | Aged, 80 and over | Adult | Female | Survival Rate | Mutation - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Drug Resistance, Neoplasm - genetics | Pyrimidines - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Clinical trials | Relapse | Tumor proteins | Diseases | Index Medicus
Hematology, Oncology and Palliative Medicine | ALEMTUZUMAB | 17P DELETION | CLL | ONCOLOGY | CYCLOPHOSPHAMIDE | RITUXIMAB | INITIAL THERAPY | BTK | OPEN-LABEL | PROLIFERATION | ELDERLY-PATIENTS | Single-Blind Method | Pyrazoles - therapeutic use | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Neoplasm Recurrence, Local - mortality | Tumor Suppressor Protein p53 - genetics | Neoplasm Recurrence, Local - pathology | Aged, 80 and over | Adult | Female | Survival Rate | Mutation - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Drug Resistance, Neoplasm - genetics | Pyrimidines - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neoplasm Staging | Clinical trials | Relapse | Tumor proteins | Diseases | Index Medicus
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 2, pp. S16 - S17
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 2, pp. S17 - S17
Journal Article
Optics Letters, ISSN 0146-9592, 01/2017, Volume 42, Issue 2, pp. 338 - 341
We demonstrate the first electrically pumped continuous-wave (CW) III-V semiconductor lasers epitaxially grown on on-axis (001) silicon substrates without...
Journal Article
IEEE Electron Device Letters, ISSN 0741-3106, 2014, Volume 35, Issue 6, pp. 621 - 623
Journal Article
19.
Full Text
Early-life exposure to endocrine disrupting chemicals associates with childhood obesity
Annals of pediatric endocrinology & metabolism, ISSN 2287-1012, 12/2018, Volume 23, Issue 4, pp. 182 - 195
Increasing prevalence of childhood obesity poses threats to the global health burden. Because this rising prevalence cannot be fully explained by traditional...
Early-life exposure | Childhood obesity | Review | Persistent organic pollutants | Endocrine disrupting chemicals
Early-life exposure | Childhood obesity | Review | Persistent organic pollutants | Endocrine disrupting chemicals
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 604 - 604
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.